SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pluristem Therapeutics
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
295 17 0 PSTI
Emcee:  FJB Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
145Pluristem Therapeutics to Present at Upcoming Industry Conferences HAIFA, Israxcentral1-5/9/2011
144Pluristem’s PLX Cells could be used for the Prevention and Treatment of Radiatioxcentral1-4/30/2011
143Pluristem Announces Encouraging Six-Month Follow-Up Results of Its Phase I Critixcentral1-4/13/2011
142Pluristem Therapeutics to Expand Testing of PLX Cells for the Treatment of Radiaxcentral1-4/6/2011
141Stem Cells From Placentas Show Potential in Treating Heart Disease, Multiple Sclxcentral1-4/4/2011
140April 4, 2011 7:27 AM EDT Needham & Company initiates coverage on Pluristexcentral1-4/4/2011
139Expert Briefing: Treating Skeletal Muscle Injuries With Pluristem's PLacentaxcentral1-4/4/2011
138Pluristem Therapeutics and NYU Medical Center Partner to Study Use of PLX Cells xcentral1-3/15/2011
137Looks like PSTI wins hands down! The battle pits Aastrom Biosciences against Plxcentral1-3/11/2011
136Corporate Profile's CPReports.com Publishes Ray Dirks Research's Update xcentral1-3/8/2011
135Pluristem Therapeutics to Present at Leading Investor Conferences HAIFA, Israexcentral1-3/7/2011
134Positive Pre-Clinical Data From Muscle Injury Study Moves Pluristem Toward Seconxcentral1-3/1/2011
133Pluristem Therapeutics' Dr. William Prather Interviewed on CorporateProfile.xcentral1-2/3/2011
132Underwriters boost Pluristem offering to $41m CEO Zami Aberman: We were very luxcentral1-1/31/2011
131After share price triples, Pluristem to raise $40-50m Jan 27, 2011 (Globes - Mxcentral1-1/28/2011
130Pluristem Announces Pricing of Public Offering of Common Stock and Warrants to Pxcentral1-1/27/2011
129theflyonthewall.com: Pluristem Therapeutics target raised to $4 from $2 at Rothxcentral1-1/25/2011
128RAY DIRKS Research Update PSTI January 24, 2011 By Ray Dirks RAY DIRKS Researchxcentral1-1/24/2011
127Pluristem on Track to Proceed to a Phase II/III Clinical Trial in Critical Limb xcentral1-1/18/2011
126Trade halted now on TASE, comp. is going to make an announcement.idos-1/18/2011
125Pluristem Therapeutic (PSTI), the Israel-based bio-therapeutics firm, is up 13% xcentral1-1/11/2011
124Globes, Tel Aviv, Israel, Tali Tsipori column Jan 09, 2011 (Globes - McClatchyxcentral1-1/10/2011
123On December 8, 2010 Mesoblast Ltd. (MBLTY.PK) and Cephalon (CEPH) announced a dexcentral1-1/6/2011
122Shares of Pluristem Therapeutics to Begin Trading on Four Equity Indexes on the xcentral1-1/4/2011
121FYI: Pluristem Therapeutics Inc. Key Recent Developments Mar 03, 2010: Receivexcentral1-12/29/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News